News FDA greenlights Roche’s biomarker blood test for Alzheimer's Roche has won US FDA clearance for a blood test that could move Alzheimer’s biomarker testing further into primary care.
News Trodelvy gets EU nod for first-line triple-neg breast cancer A new EC authorisation expands Gilead's market for triple-negative breast cancer ADC Trodelvy.
News Ultragenyx wins FDA approval for first treatment targeting r... Ultragenyx secured its first gene therapy approval, the FDA clearing GENGLYCOS as the first treatment designed to address underlying cause of GSDla.
News Trump taps White House aide Heidi Overton to lead FDA US President Donald Trump has nominated White House health policy aide Heidi Overton to take up the mantle of FDA commissioner.
R&D Understanding Operation Trialblazer, with Dr Harpreet Singh Dr Harpreet Singh, CMO at Precision for Medicine, brings both an insider and outsider perspective to discussing Operation TRIALBLAZER.
News Capricor’s DMD hope still strong, as it shares financials Capricor shares second quarter financials as FDA reconsiders BLA for DMD therapy deramiocel.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.